Journal Article

Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens

Kim, Taejoong, Suarez, David L., Lee, Chang-Won, Spackman, Erica, Lee, Jiho, Lee, Scott A.

2024

Overview

The outbreak of clade 2.3.4.4b H5 highly pathogenic avian influenza (HPAI) in North America that started in 2021 has increased interest in applying vaccination as a strategy to help control and prevent the disease in poultry. Two commercially available vaccines based on the recombinant herpes virus of turkeys (rHVT) vector were tested against a recent North American clade 2.3.4.4b H5 HPAI virus isolate: A/turkey/Indiana/22-003707-003/2022 H5N1 in specific pathogen free white leghorn (WL) chickens and commercial broiler chickens. One rHVT-H5 vaccine encodes a hemagglutinin (HA) gene designed by the computationally optimized broadly reactive antigen method (COBRA-HVT vaccine). The other encodes an HA gene of a clade 2.2 virus (2.2-HVT vaccine). There was 100% survival of both chicken types COBRA-HVT vaccinated groups and in the 2.2-HVT vaccinated groups there was 94.8% and 90% survival of the WL and broilers respectively. Compared to the 2.2-HVT vaccinated groups, WL in the COBRA-HVT vaccinated group shed significantly lower mean viral titers by the cloacal route and broilers shed significantly lower titers by the oropharyngeal route than broilers. Virus titers detected in oral and cloacal swabs were otherwise similar among both vaccine groups and chicken types. To assess antibody-based tests to identify birds that have been infected after vaccination (DIVA-VI), sera collected after the challenge were tested with enzyme-linked lectin assay-neuraminidase inhibition (ELLA-NI) for N1 neuraminidase antibody detection and by commercial ELISA for detection of antibodies to the NP protein. As early as 7 days post challenge (DPC) 100% of the chickens were positive by ELLA-NI. ELISA was less sensitive with a maximum of 75% positive at 10DPC in broilers vaccinated with 2.2-HVT. Both vaccines provided protection from challenge to both types of chickens and ELLA-NI was sensitive at identifying antibodies to the challenge virus therefore should be evaluated further for DIVA-VI.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: 60 APPLIED LIFE SCIENCES / Animals / Antibodies / Antibodies, Viral - blood / Antibodies, Viral - immunology / antibody detection / Antigens / Avian flu / Avian influenza / Biology and Life Sciences / Birds / Chickens / Chickens - immunology / Chickens - virology / cloaca / Disease control / Drug therapy / Eggs / Enzyme-linked immunoassays / Enzyme-linked immunosorbent assay / Epidemics / Exo-a-sialidase / genes / Hemagglutinin Glycoproteins, Influenza Virus - genetics / Hemagglutinin Glycoproteins, Influenza Virus - immunology / Hemagglutinins / Herpes viruses / Herpesvirus 1, Meleagrid - genetics / Herpesvirus 1, Meleagrid - immunology / Infections / Influenza / Influenza A virus / Influenza A Virus, H5N1 Subtype - genetics / Influenza A Virus, H5N1 Subtype - immunology / Influenza in Birds - immunology / Influenza in Birds - prevention & control / Influenza in Birds - virology / Influenza vaccines / Influenza Vaccines - administration & dosage / Influenza Vaccines - immunology / Influenza viruses / Laboratories / Lectins / Licenses / Medicine and Health Sciences / Morbidity / Mortality / North America / NP protein / Poultry / Poultry Diseases - immunology / Poultry Diseases - prevention & control / Poultry Diseases - virology / Research and Analysis Methods / Science & Technology - Other Topics / Sensitivity analysis / sialidase / Specific pathogen free / specific pathogen-free animals / Surveillance / Survival / Turkeys / Vaccination / Vaccine development / Vaccines / Vaccines, Synthetic - administration & dosage / Vaccines, Synthetic - immunology / Viral release / Viral vaccines / Viruses / White Leghorn